The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran

被引:0
作者
Mohammadreza Amirsadri
Sarah Mousavi
Ali Karimipour
机构
[1] Isfahan University of Medical Sciences,Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences
[2] Isfahan University of Medical Sciences,Isfahan Pharmaceutical Sciences Research Center
[3] Isfahan University of Medical Sciences,School of Pharmacy and Pharmaceutical Sciences
来源
DARU Journal of Pharmaceutical Sciences | 2019年 / 27卷
关键词
Economic evaluation; Enoxaparin; Heparin; Venous thromboembolism; Medical inpatients;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:627 / 634
页数:7
相关论文
共 75 条
[1]  
Tagalakis V(2013)Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort Am J Med 126 832. e13-832. e21
[2]  
Patenaude V(2003)Risk factors for venous thromboembolism Circulation. 107 I-9-I-16
[3]  
Kahn SR(2013)Venous thromboembolism prophylaxis Clin Colon Rectal Surg 26 153-159
[4]  
Suissa S(2012)New insights into the mechanisms of venous thrombosis J Clin Invest 122 2331-2336
[5]  
Anderson FA(2015)Estimated prevalence of venous thromboembolism in Iran: prophylaxis still an unmet challenge Tanaffos. 14 27-33
[6]  
Spencer FA(2010)Risk assessment as a guide for the prevention of the many faces of venous thromboembolism Am J Surg 199 S3-S10
[7]  
Laryea J(2008)Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective Arch Intern Med 168 706-712
[8]  
Champagne B(2014)Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism Blood. 123 1794-1801
[9]  
Mackman N(2000)Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials Thromb Haemost 83 14-19
[10]  
Sharif-Kashani B(2010)Intracranial and fatal bleeding according to indication for long-term oral anticoagulant therapy J Thromb Haemost 8 2201-2207